Netazepide is an orally active, benzodiazepine-type selective antagonist of the cholecystokinin B receptor (CCKBR), also known as the gastrin receptor. By blocking these receptors, the drug inhibits gastrin-mediated… Read more
Netazepide is an orally active, benzodiazepine-type selective antagonist of the cholecystokinin B receptor (CCKBR), also known as the gastrin receptor. By blocking these receptors, the drug inhibits gastrin-mediated stimulation of gastric parietal cells, offering potential therapeutic applications in managing conditions associated with gastric acid hypersecretion and hypergastrinaemia, such as gastric neuroendocrine tumours. To support the development and regulation of this agent, pharmaceutical laboratories rely on high-quality reference standards for rigorous quality control. This category includes comprehensive analytical tools such as Netazepide impurity standards, metabolites, and stable isotope-labelled compounds. These materials are essential for precise impurity profiling, enabling scientists to detect, identify, and quantify trace contaminants throughout the manufacturing and storage process. By utilizing these standardized materials, laboratories can ensure the robustness of their analytical testing, facilitate method validation, and maintain consistent compliance with regulatory standards for drug purity and safety.